Music |
Video |
Movies |
Chart |
Show |
Interview Prof. A. Hagenbeek, EHA 2015 (Uitgeverij Jaap (Oncologie.nu)) View | |
Small, smart molecules in cancer treatment - Prof Hagenbeek (Patient Power Europe) View | |
Prof. Hagenbeek discusses brentuximan vedotin advances in HL and DLBCL revealed at 13-ICML (Lymphoma Hub) View | |
Prof. Anton Hagenbeek case study presentation (Secretariat Lymphoma Hub) View | |
Highlights from EHA 2013 (ecancer) View | |
Anton Hagenbeek | EHA 2018 | Relevant findings of the RELEVANCE phase III study (Lymphoma Hub) View | |
Immunoconjugates address unmet needs in Hodgkin's lymphoma patients (ecancer) View | |
ASH 2010: First-line Indolent Trial (FIT) study (ecancer) View | |
Highlights from EHA 2016 press briefings: Nivolumab, SGN-CD33A and hemophilia (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
Interview Prof. dr. ir. J.J.M. van der Hoeven, medisch oncoloog (Uitgeverij Jaap (Oncologie.nu)) View |